Atlas market file · Equity · United States
Airsculpt Technologies, Inc.AIRS
- Last close
- 4.77
- Change
- -3.64%
- 96-bar range
- 2.34 – 5.79
- As of
- 6 Aug 2026
Airsculpt Technologies, Inc. is a services-offices & clinics of doctors of medicine issuer listed as AIRS on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
AIRS
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+6.24% over the window).
Source rail: Yahoo Finance chart API (AIRS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for AIRS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
AIRS public profile
Services-offices & clinics of doctors of medicine issuer. Airsculpt Technologies, Inc. is connected to current market context, cited company sources and its retained research file.
Airsculpt Technologies, Inc. trades as AIRS on NASDAQ. Airsculpt Technologies, Inc. (AIRS) has a latest verified close of 4.77, down 3.64%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files AIRS under USA Stocks and Technology Stocks for browsing.
What changed for Airsculpt Technologies, Inc. today
AirSculpt Technologies, Inc. reported a net income loss of $2.4 million for the period ending March 31, 2026, which raises concerns about the company's financial health.
The company's business model revolves around providing premium body contouring procedures, with a focus on same center sales, which increased by 1% compared to the same period in 2025.
According to the company's 10-Q filing, revenue from contract with customers, excluding assessed tax, was $39.4 million, while operating income loss was $1.8 million, and net cash provided by operating activities was $5.3 million (source: SEC EDGAR, https://www.sec.gov/Archives/edgar/data/1870940/000187094026000028/airs-20260331.htm).
The company's financials also show a cash and cash equivalents balance of $16.7 million, and a stockholders' equity attributable to parent of $100.3 million, which may provide some cushion for the company's operations (source: SEC EDGAR, https://www.sec.gov/Archives/edgar/data/1870940/000187094026000028/airs-20260331.htm).
The company's next steps and ability to generate profits will be crucial in determining its future success, and the source directs readers to closely monitor the company's financials and business developments (source: Official product/news rail, https://www.sec.gov/Archives/edgar/data/1870940/000187094026000026/a8-kexhibit9913312026.htm).
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
AIRS technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on AIRS
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep AIRS research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
AIRS FAQ
What is Airsculpt Technologies, Inc. (AIRS)?Airsculpt Technologies, Inc. (AIRS) has a latest verified close of 4.77, down 3.64%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Airsculpt Technologies, Inc. (AIRS) has a latest verified close of 4.77, down 3.64%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for AIRS?Airsculpt Technologies, Inc. (AIRS) has a latest verified close of 4.77, down 3.64%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
Airsculpt Technologies, Inc. (AIRS) has a latest verified close of 4.77, down 3.64%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files AIRS under USA Stocks and Technology Stocks for browsing.
How often is the AIRS page updated?The AIRS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The AIRS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for AIRS?The AIRS file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:AIRS. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The AIRS file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:AIRS. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on AIRS?Yes. The workstation can open AIRS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open AIRS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this AIRS page investment advice?No. The AIRS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The AIRS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →